Skip to content

Study · Animal study (in vivo) · mouse · 1995

1 result

[The effect of different classes of radioprotectors on the survival of mice irradiated at a wide range of doses].

Boĭko VN, Zholus RB, Legeza VI

Radiatsionnaia biologiia, radioecologiia1 Jul 1995

PMID7581804 (opens in a new tab)PepBankPUB-07581804

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In irradiated mice, thymogen showed maximum protection in the LD50-70/30 dose range.

    In plain wordsIn mice exposed to radiation, thymogen showed maximum protection in the LD50-70/30 dose range.

    Outcome
    Not applicableDose range of maximum radioprotection
    Study

    mousen: not reported in source

    irradiated mice
    Outcome group
    Mortality · Whole body
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Maximum protection was revealed in the ranges of LD70-100/30 for naphthyzin and cystamine, LD50-70/30 for thymogen and lymphokinin, LD70/30 for prodigiosan and polyribonate.
    1 context sentence
    Summary · context
    In experiments with mice three kinds of dose dependence of radioprotection efficiency were shown for different radioprotectors.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.